Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03617770 · ClinicalTrials.gov registry record · NA
A Sleep Intervention in Type 1 Diabetes
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03617770 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 14 participants.
The verdict
NCT03617770, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Insufficient sleep and sleep irregularity (variability in sleep duration) are increasingly recognized as important contributors to glucose control and diabetes distress in type 1 diabetes (T1D). Up to 40% of adults with T1D had a sleep duration less than 6-6.5 hours per night. Diabetes distress is reported (40% prevalence) in individuals with T1D and is associated with poor glucose control. Despite findings that sleep disturbances are common in T1D, the current understanding of the effects of strategies to improve sleep on diabetes distress, and glucose control is limited. The purpose of this pilot study is to evaluate the effects of a sleep intervention on sleep duration, diabetes distress and glucose control in individuals with T1D and habitual short sleep. A randomized controlled trial in 20 adults aged 18 to 65 years with T1D is proposed. Eligible participants will be randomly assigned to a sleep intervention group or a control group. Differences between the two groups on the outcomes of sleep duration, diabetes distress and glucose control will be evaluated. Findings from this proposed pilot study will serve as the foundation for a larger clinical trial to improve sleep, reduce diabetes distress, and improve glucose control.
Interventions
- BEHAVIORAL Healthy Living
- BEHAVIORAL Sleep Opt-In
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-01-09 |
| Est. Completion | 2019-11-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03617770
The ClinicalTrials.gov registry entry for NCT03617770 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Healthy Living is the first listed.
NCT03617770 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03617770 about?
NCT03617770 is a clinical study titled "A Sleep Intervention in Type 1 Diabetes". Insufficient sleep and sleep irregularity (variability in sleep duration) are increasingly recognized as important contributors to glucose control and diabetes distress in type 1 diabetes (T1D). Up to 40% of adults with T1D had a sleep duration less than 6-6.5 hours per night. Diabetes distress is r...
What is the current status of trial NCT03617770?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2019-01-09. Estimated completion is 2019-11-20.
What interventions are being tested in trial NCT03617770?
The interventions under investigation include: Healthy Living (BEHAVIORAL), Sleep Opt-In (BEHAVIORAL).
Who is sponsoring clinical trial NCT03617770?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.